Analyzing the activity of CD133 and ALDH, Akunuru S. et al. came to the conclusion that separated tumor stem cells (CD133+ ALDHhigh) can mutually transform from non-CSC (CD133- or ALDHlow) (Akunuru et al., 2012). The gene discussed is PROM1; the disease is neoplasm.